Targeting RARγ Decreases Immunosuppressive Macrophage Polarization and Reduces Tumor Growth

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Tumor-associated macrophages (TAMs) are key players in the tumor microenvironment (TME), promoting tumor growth and therapy resistance.
• TAMs often display immunosuppressive M2-like phenotypes, hindering anti-tumor immune responses.
• Regulating TAM activity is crucial for improving cancer treatment outcomes.

Purpose of the Study:

• To identify key regulators of immunosuppressive polarization in TAMs.
• To investigate the role of retinoic acid receptor gamma (RARγ) in TAM function.
• To evaluate RARγ inhibition as a potential therapeutic strategy against cancer.

Main Methods:

• Utilized THP-1 macrophages to study immunosuppressive polarization.
• Employed small molecule inhibitors and gene silencing to inhibit RARγ.
• Assessed the expression of immunosuppressive macrophage markers.
• Used a three-dimensional tumor spheroid model with HCT116 colorectal cancer cells.

Main Results:

• Retinoic acid receptor gamma (RARγ) was identified as a key regulator of immunosuppressive macrophage polarization.
• Inhibition of RARγ significantly reduced the expression of immunosuppressive macrophage markers.
• RARγ inhibition hindered the proliferation of colorectal cancer cells in a tumor spheroid model.

Conclusions:

• Targeting RARγ reprograms immunosuppressive TAMs towards a less tumor-promoting phenotype.
• RARγ inhibition mitigates the pro-tumorigenic effects of TAMs.
• RARγ represents a promising therapeutic target for novel anti-cancer strategies.